|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
-1.29/5.57
|
Enterprise Value
24.94B
|
Balance Sheet |
Book Value Per Share
-3.20
|
Cash Flow |
Cash Flow Yield
0.42
|
Income Statement |
Total Revenue
8.76B
|
Operating Revenue Per Share
23.27
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2024/09/21 01:28 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment. |